Shareholders Elect Camblong as Chairman with 99.79%, Appoint Muken as CEO Effective July 1
SOPH•Shareholders approved all 2026 AGM proposals, electing co-founder Dr. Jurgi Camblong as Executive Chairman with 99.79% support and Ross Muken to the board with 99.88%, who will become CEO on July 1, 2026. They also ratified aggregate compensation limits, a share replenishment amendment and the 2025 financial statements.
1. AGM Approvals and Leadership Elections
At the 2026 Annual General Meeting, shareholders approved all proposals, electing Dr. Jurgi Camblong as Executive Chairman with 99.79% support and Ross Muken as a new board member with 99.88% support. Other incumbents were re-elected for one-year terms, and PricewaterhouseCoopers SA was confirmed as external auditor for 2026.
2. Executive Leadership Transition
Ross Muken will assume the Chief Executive Officer role on July 1, 2026, marking his first year on the board, while co-founder Jurgi Camblong transitions from CEO to Executive Chairman to focus on long-term strategic, scientific and technological direction of the company.
3. Compensation, Financials, and Governance Updates
Shareholders ratified maximum aggregate compensation limits for the board and executive committee, approved a share replenishment amendment under the 2021 Equity Incentive Plan, accepted the 2025 financial statements and ESG impact summary, and endorsed a rotating Lead Independent Director role to strengthen board governance.
